PDGFRA and gastrointestinal stromal tumor: Overall, in the PDGFRA D842V mutant GIST population (56 patients), 5 (9%) had a complete response, 44 (79%) had a partial response, and 7 (13%) had stable disease; PFS was 81% at 12 months (67).